An ETH Zurich start-up, Piomic Medical is developing COMS One, a portable, non-invasive device for treating chronic wounds. It has closed a USD 25 million growth round led by Swisscanto, to complete its clinical trials and prepare approval and launch in the United States.
- Announced on
- Round
- Growth
- Amount
- USD 25 M
- Location
- canton of Zurich
- Sector
- Health & medtech
Investors
- Swisscanto lead
- Diabetes Venture Fund
- Zürcher Kantonalbank
- Verve Ventures
- Sky Stiftung
- N&V Capital
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic